시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
Fill-Finish 제조 시장 규모, 점유율, 예측 및 동향 분석 : 제공(포장 유형, 장비, 서비스), 제제(경구용, 비경구용), 용도(생물학적 제제, 저분자)별, 최종 사용자별 - 세계 예측(-2031년)
Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User - Global Forecast to 2031
상품코드 : 1504161
리서치사 : Meticulous Research
발행일 : On Demand Report
페이지 정보 : 영문 550 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,175 ￦ 6,059,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,875 ￦ 8,526,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,875 ￦ 11,429,000
PDF (Global Site License) help
PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

Fill-Finish 제조 시장은 2031년까지 191억 4,000만 달러에 달할 것으로 예상되며, 2024-2031년간 연평균 9.9%의 성장률을 나타낼 전망입니다.

이 보고서는 광범위한 2차 및 1차 조사, 그리고 충전 마감 제조 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 도전 과제 및 기회 분석으로 구성되어 있습니다. 충전 마감 제조 시장의 성장은 바이오 제약 산업의 성장, 제약 및 바이오 제약 기업의 생산 능력 확대 노력, 충전 마감 제조 공정의 발전, 프리필드시린지 수요 증가에 힘입어 성장하고 있습니다. 그러나 높은 운영 비용과 제조 공정 전반에 걸쳐 약물의 효능을 유지해야 하는 문제점이 시장 성장을 저해할 수 있습니다.

또한, 백신 접종률 향상을 위한 노력, 바이오시밀러 개발에 대한 관심 증가, 신규 생물학적 제제 개발에 대한 투자 증가는 시장 성장의 기회를 창출할 것으로 예상됩니다. 그러나 완제의약품 제조에 대한 엄격한 규제 요건과 용량을 정확하게 채우는 데 따르는 복잡성은 시장 성장을 저해하는 요인으로 작용할 수 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

제5장 Fill-Finish 제조 시장 : 제공 제품별 평가

제6장 제제별 Fill-Finish 제조 시장 평가

제7장 멸균 프로세스별 Fill-Finish 제조 시장 평가

제8장 용도별 Fill-Finish 제조 시장 평가

제9장 최종사용자별 Fill-Finish 제조 시장 평가

제10장 지역별 Fill-Finish 제조 시장 평가

제11장 경쟁 분석

제12장 기업 개요(기업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개, SWOT 분석*)

(주 : 주요 5개사의 SWOT 분석을 게재)

제13장 부록

LSH
영문 목차

영문목차

Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User-Global Forecast to 2031

The Fill-finish Manufacturing Market is Projected to Reach $19.14 Billion by 2031, at a CAGR of 9.9% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the fill-finish manufacturing market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the fill-finish manufacturing market is driven by the growth of the biopharmaceutical industry, initiatives by pharmaceutical & biopharmaceutical companies to expand their production capacities, advancements in fill-finish manufacturing processes, and the increasing demand for pre-filled syringes. However, high operational costs and challenges in maintaining drug potency throughout the manufacturing process may restrain the market's growth.

Moreover, initiatives aimed at increasing vaccination rates, increasing focus on biosimilar development, and rising investments in the development of new biologics are expected to create market growth opportunities. However, stringent regulatory requirements governing fill-finish manufacturing and the complexities associated with accurately filling specific medication doses are some of the challenges impeding the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the fill-finish manufacturing market are Syntegon Technology GmbH (Germany), Becton, Dickinson and Company (U.S.), Industria Macchine Automatiche S.p.A. (Italy), West Pharmaceutical Services, Inc. (U.S.), Catalent, Inc. (U.S.), AbbVie Inc. (U.S.), Gerresheimer AG (Germany), AptarGroup, Inc. (U.S.), OPTIMA packaging group GmbH (Germany), Baxter International Inc. (U.S.), C.H. Boehringer Sohn AG & Co. KG (Germany), Schott Pharma AG & Co. KGaA (Germany), SGD Pharma (France), and Stevanato Group (Italy).

Among the offerings covered in this report, in 2024, the packaging type segment is expected to account for the largest share of the fill-finish manufacturing market. The packaging type segment is further sub-segmented into vials, syringes, cartridges, ampoules, and accessories. The large market share of this segment is attributed to the increasing approval for biologics, increasing demand for parenteral formulations, recurring demand for fill-finish packaging, and advancements in fill-finish technology. Additionally, there is an increasing demand for fill-finish services is increasing for vials, cartridges, and other packaging types to reduce product wastage and maintain sterility while filling the drug.

Among the formulations covered in this report, in 2024, the parenteral segment is expected to account for the largest share of the fill-finish manufacturing market. Vials, syringes, cartridges, and ampoules are commonly used for the packaging of parenteral drug formulations. The increasing demand for injectables, technological advancements in materials, and designs of pre-fillable syringes and vials are contributing to the large market share of this segment. Additionally, the increasing number of approvals for injectables is further contributing to the segment growth. For instance, in September 2023, Pfizer Inc. (U.S.) and BioNTech SE (Germany) obtained supplemental Biologics License Application approval from the U.S. FDA for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine.

Among the sterilization processes covered in this report, in 2024, the aseptic processing segment is expected to account for the largest share of the fill-finish manufacturing market. The demand for aseptic processing is driven by the need to sterilize heat-sensitive drugs such as biologics, vaccines, and other parenteral medications. Moreover, there is a growing demand for aseptic processing for handling heat-sensitive drugs such as antibiotics, nasal sprays, ear drops, oral drops, and diabetes medications.

Among the applications covered in this report, the biologics segment is projected to register a higher CAGR during the forecast period. The segment's rapid growth can be attributed to the rising demand for biologics, expansion of biologics manufacturing facilities, rising approvals for biologic products, and product launches by key market players. For instance, in June 2023, UCB (Belgium), a biopharmaceutical company, received U.S. FDA approval for RYSTIGGO (rozanolixizumab-noli) under Priority Review designation for the treatment of generalized myasthenia gravis (gMG) in adult patients.

Among the end users covered in this report, in 2024, the CROs & CDMOs segment is expected to account for the largest share of the fill-finish manufacturing market. The surge in clinical trials and rapid growth in the healthcare and life sciences sectors are accelerating the outsourcing trend to ensure efficient and cost-effective drug filling. Additionally, strategic partnerships between pharmaceutical companies and CROs & CDMOs and stringent regulatory requirements governing fill-finish processes are contributing to the largest share of the segment.

An in-depth analysis of the geographical scenario of the global fill-finish manufacturing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of over 11.3% during the forecast period. The growth of this regional market is driven by the growth of the pharmaceutical market, increasing investments in R&D by pharmaceutical & biopharmaceutical companies, and favorable regulatory policies. Additionally, China has become an attractive destination for international pharmaceutical companies seeking to streamline product timelines and minimize production costs.

Scope of the Report:

Fill-finish Manufacturing Market Assessment-by Offering

Note: Other Materials include rubber, metal, and paper.

Other Packaging Instruments include powder sachet filling & packaging equipment, nested filling systems, tube filling equipment, and cream filling equipment.

Other Packaging Services include capsule filling, tube filling, sachet filling, and powder filling.

Fill-finish Manufacturing Market Assessment-by Formulation

Note: Other Formulations include nasal, ocular, intradermal, and transcutaneous (TC) formulations

Fill-finish Manufacturing Market Assessment-by Sterilization Process

Fill-finish Manufacturing Market Assessment-by Application

Fill-finish Manufacturing Market Assessment-by End User

Fill-finish Manufacturing Market Assessment-by Geography

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Fill-finish Manufacturing Market Assessment-by Offering

6. Fill-finish Manufacturing Market Assessment-by Formulation

7. Fill-finish Manufacturing Market Assessment-by Sterilization Process

8. Fill-finish Manufacturing Market Assessment-by Application

9. Fill-finish Manufacturing Market Assessment-by End User

10. Fill-finish Manufacturing Market Assessment-by Geography

11. Competition Analysis

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

(Note: SWOT Analyses of the Top 5 Companies Will Be Provided.)

13. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기